Research And Development
100 Most Popular
Medical Devices

TransEnterix

$1.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (2.21%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell TransEnterix and other stocks, options, ETFs, and crypto commission-free!

About TRXC

TransEnterix, Inc., also called TransEnterix, is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. Read More It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.

Employees
189
Headquarters
Morrisville, North Carolina
Founded
2006
Market Cap
301.79M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.92M
High Today
$1.41
Low Today
$1.36
Open Price
$1.37
Volume
744.65K
52 Week High
$6.98
52 Week Low
$1.03

Collections

Research And Development
100 Most Popular
Medical Devices
Medical
Health
US
North America

TRXC News

BenzingaJul 10

Transenterix Spikes Higher After Equity Investment, AutoLap Asset Sale

4,712

TRXC Earnings

-$0.09
-$0.08
-$0.07
-$0.06
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours

Popular Stocks

More TRXC News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.